Sunovion Pharmaceuticals Inc. · Marlborough, MA United States
| 84 Waterford Dr. | Phone: 508-481-6700 |
| Marlborough, MA | Fax: 508-357-7499 |
| 01752 | |
| United States | 
Map This Company |
Sunovion Pharmaceuticals Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Helping people breathe easy and sleep properly are the core of Sunovion (formerly Sepracor). The company focuses its drug development efforts in two main therapeutic categories: respiratory and central nervous system (CNS) disorders. Among its six marketed products are asthma drug Xopenex, insomnia therapy Lunesta, and chronic obstructive pulmonary disease (COPD) treatment Brovana. Sunovion markets its products to primary care physicians and some specialists in the US. It has licensed international development and commercialization rights for Lunesta to
Sunovion Pharmaceuticals Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | SubsidiaryHeadquarters |
|---|---|
| Fiscal Year-End | December |
| 2009 Employees | 2,068 |
Executives
91 executives listed for Sunovion Pharmaceuticals Inc.'s Marlborough, MA location.
| Chairman and CEO | Saburo Hamanaka | |
|---|---|---|
| President, COO, and Director | Mark Iwicki | |
| EVP and Chief Scientific Officer | Nobuhiko Tamura |